Oschatz Elisabeth, Benesch Thomas, Kodras Katharina, Hoffmann Udo, Haas Martin
Department of Radiology, Institute for Medical Statistics.
Am J Kidney Dis. 2006 Aug;48(2):307-13. doi: 10.1053/j.ajkd.2006.04.066.
Coronary artery calcification (CAC) in patients with end-stage renal disease is driven by uremia and increased serum calcium and phosphate levels. Improvement in calcium-phosphate homeostasis and uremia by kidney transplantation therefore might favorably influence CAC.
We measured the extent of CAC by using multidetector computed tomography in 31 patients immediately after transplantation and at 6 and 12 months' follow-up. Baseline and follow-up measurements were compared, and the effect of atherogenic factors on CAC progression was determined by means of multivariate regression analysis.
Mean total Agatston score increased significantly from baseline to 6 months (716 +/- 980 [SD] versus 916 +/- 1,307; P < 0.001), but remained unchanged at 12 months' follow-up (890 +/- 1,263; P = not significant). Progression of calcification was present only in patients with a baseline total Agatston score higher than 10. In these patients, the score increased from 964 +/- 1,028 to 1,234 +/- 1,385 (P < 0.001) at 6 months and remained stable thereafter (1,199 +/- 1,338; P = not significant). Duration of pretransplantation dialysis treatment and smoking were identified as independent predictors of posttransplantation CAC progression. Conversely, changes in calcium and phosphate levels were not associated with calcification.
This study shows that CAC progresses during the early posttransplantation course, but slows between 6 and 12 months after transplantation. The extent of early calcification is influenced mainly by dialysis treatment duration and smoking.
终末期肾病患者的冠状动脉钙化(CAC)是由尿毒症以及血清钙和磷水平升高所驱动的。因此,肾移植改善钙磷稳态和尿毒症可能会对CAC产生有利影响。
我们使用多排螺旋计算机断层扫描对31例患者在移植后即刻以及随访6个月和12个月时的CAC程度进行了测量。比较了基线和随访测量结果,并通过多变量回归分析确定了致动脉粥样硬化因素对CAC进展的影响。
平均总阿加斯顿积分从基线到6个月时显著增加(716±980[标准差]对916±1307;P<0.001),但在12个月随访时保持不变(890±1263;P=无显著性差异)。钙化进展仅出现在基线总阿加斯顿积分高于10的患者中。在这些患者中,积分在6个月时从964±1028增加到1234±1385(P<0.001),此后保持稳定(1199±1338;P=无显著性差异)。移植前透析治疗时间和吸烟被确定为移植后CAC进展的独立预测因素。相反,钙和磷水平的变化与钙化无关。
本研究表明,CAC在移植后早期病程中进展,但在移植后6至12个月之间减缓。早期钙化程度主要受透析治疗时间和吸烟的影响。